← All trials
NCT04323657
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 27, 2020
- Primary completion
- Apr 30, 2022
- Completion date
- Apr 30, 2024
- First posted
- Mar 26, 2020
- Last posted
- Apr 7, 2020
- Enrollment
- 120
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- TCR2 TherapeuticsLead sponsor
- TCR2 TherapeuticsStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.